Subgroups
Outcomes (21)
- survival-graft-versus-host-disease-free-relapse-free-probability
- survival-mortality-all-cause-count-cohort-measured
- survival-mortality-all-cause-in-hospital-rate-percent-cohort-measured
- survival-mortality-all-cause-rate-1-year-percent-cohort-measured
- survival-mortality-all-cause-rate-per-1000-person-years-measured
- survival-mortality-cardiovascular-death-rate-per-1000-person-years-measured
- survival-mortality-cardiovascular-major-adverse-cardiac-event-hospitalization-or-emergency-rate-per-1000-person-years-measured
- survival-mortality-cardiovascular-major-adverse-cardiac-event-mace-count-cohort-measured
- survival-mortality-cardiovascular-major-adverse-cardiac-event-rate-per-1000-person-years-measured
- survival-mortality-cardiovascular-nonfatal-myocardial-infarction-count-cohort-measured
- survival-mortality-cardiovascular-nonfatal-stroke-count-cohort-measured
- survival-mortality-cardiovascular-rehospitalization-heart-failure-myocardial-infarction-rate-percent-1-year-cohort-measured
- survival-mortality-cardiovascular-ventricular-tachycardia-fibrillation-death-first-occurrence-binary
- survival-mortality-cardiovascular-ventricular-tachycardia-recurrent-episode-count-cohort-measured
- survival-mortality-hospital-discharge-stable-clinically-achieved-binary-measured
- survival-mortality-hospital-stay-duration-days-measured
- survival-mortality-non-cardiovascular-rate-per-1000-person-years-measured
- survival-mortality-readmission-rate-30-day-percent-cohort-measured
- survival-overall-probability
- survival-progression-free-probability
- survival-treatment-related-mortality-cumulative-incidence
Protocols & scoring
exercise-structured-program-counseling-generic1 evidence row
medication-antihypertensive-generic-protocol1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-mortality-hospital-stay-duration-days-measured | +55 | 85 | 19 |
medication-ranolazine-twice-daily-protocol1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-mortality-all-cause-in-hospital-rate-percent-cohort-measured | +65 | 50 | 800 |
therapy-st-elevation-myocardial-infarction-emergency-cath-lab-activation-handoff-transfer-radial-first-pci-protocol1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-mortality-all-cause-in-hospital-rate-percent-cohort-measured | +70 | 45 | 43 |
| survival-mortality-all-cause-rate-1-year-percent-cohort-measured | +15 | 25 | 43 |
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-graft-versus-host-disease-free-relapse-free-probability | -30 | 55 | 187 |
| survival-overall-probability | 0 | 50 | 193 |
| survival-progression-free-probability | -15 | 45 | 193 |
| survival-treatment-related-mortality-cumulative-incidence | +10 | 40 | 193 |
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-graft-versus-host-disease-free-relapse-free-probability | +30 | 55 | 97 |
| survival-overall-probability | 0 | 50 | 97 |
| survival-progression-free-probability | +15 | 45 | 97 |
| survival-treatment-related-mortality-cumulative-incidence | -10 | 40 | 97 |
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-mortality-hospital-stay-duration-days-measured | +45 | 60 | 513 |
| survival-mortality-readmission-rate-30-day-percent-cohort-measured | -25 | 55 | 513 |
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-mortality-hospital-stay-duration-days-measured | +45 | 85 | 4375 |
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| survival-mortality-hospital-discharge-stable-clinically-achieved-binary-measured | +90 | 50 | 1 |
Path: survival